Atrial Fibrillation: Perspective

• Jul 26 2024 This Week in Cardiology   Health and income, high BP in the hospital, and more on subclinical AF and when to use anticoagulants are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, July 26, 2024
• Jul 19 2024 This Week in Cardiology   Vulnerable plaque and scientific method; industry payments to trainees; tirzepatide or semaglutide; trial interpretation; and PFA are the topics John Mandrola, MD, covers in today’s podcast.
  theheart.org on Medscape, July 19, 2024
• Are US Electrophysiologists Too Easily Impressed? Electrophysiologists adopt new things a little too enthusiastically, writes John Mandrola, MD, of a new technique to treat atrial fibrillation.
  theheart.org on Medscape, July 17, 2024
• Jul 12 2024 This Week in Cardiology   Venous closure devices, GLP1-s linked to blindness and cancer, resisting the urge to do an ECG, and transcatheter edge-to-edge repair (TEER) for secondary mitral regurgitation are the topics discussed this week.
  theheart.org on Medscape, July 12, 2024
• Atrial Fibrillation Linked to Dementia in T2D New-onset atrial fibrillation is an independent risk factor for all-cause dementia in patients with T2D, who are more prone to both conditions, says UK Biobank data analysis.
  Medscape Medical News, July 12, 2024
• Lower Edoxaban Dose Reduces Bleeding in Elderly Patients Dose reductions of edoxaban in patients over 80 years of age with atrial fibrillation produced a lower risk for bleeding.
  Medscape Medical News, July 11, 2024
• Jun 28 2024 This Week in Cardiology   Screening echo, multivitamins, wasteful research, another PA sensor for HF, vascular closure devices, and GLP-1 marketing as science research are the topics John Mandrola, MD, discusses this week.
  theheart.org on Medscape, July 01, 2024
• Noncancerous Thyroidology Highlights From ENDO 2024   Key data in thyroid disease from ENDO 2024 include teprotumumab therapy for treatment of thyroid eye disease, a study in thyroid storm, and use of mimetic medications to treat steatotic liver disease.
  Medscape, June 25, 2024
• ESOC 2024 Top Studies From ESOC 2024 in Review Christoph Diener, MD, PhD, discusses his picks for the top studies presented at the 2024 European Stroke Organisation Congress in Switzerland.
  Medscape Neurology, June 19, 2024
• Episode 1: A Global Health Tidal Wave? Cardiorenal Metabolic Syndrome   Join Drs Nihar Desai and Chiadi Ndumele as they define and discuss cardiorenal metabolic syndrome, a chronic health condition with the potential to impact up to 90% of the US population.
  Medscape, June 18, 2024
• Jun 14 2024 This Week in Cardiology   Listener feedback, statin eligibility and Yogi Berra, evidence-based medicine and heterogenous treatment effects, and MRAs in HF are the topics John Mandrola, MD, discusses in this week’s podcast.
  theheart.org on Medscape, June 14, 2024
• Heart Failure in Women: Key Differences and Clinical Tips   Eileen Hsich, MD, discusses the underlying causes of heart failure and treatment responses to therapy in women.
  American College of Cardiology & Medscape , June 14, 2024
• Jun 07 2024 This Week in Cardiology   Cannabis and CV outcomes, post-CABG AF, embolic protection devices, emulation of randomization, and a preview heterogenous treatment effects are the topics John Mandrola, MD, covers this week.
  theheart.org on Medscape, June 07, 2024
• Who Benefits From Omega-3/Fish Oil Supplements?   Dr JoAnn Manson reviews recent data on benefits and harms of omega-3/fish oil supplementation.
  Medscape Ob/Gyn, June 04, 2024
• May 31 2024 This Week in Cardiology   The FLOW trial of semaglutide, the DANCAVAS CV screening trial, non-invasive tests for chest pain, and conflicts of interest on social media are the topics John Mandrola, MD, discusses this week.
  theheart.org on Medscape, May 31, 2024
• May 24 2024 This Week in Cardiology   Clues in SCAF, a DOAC antidote trial, another negative lytic trial in stroke, JAMA changes to observational studies, and BP in stroke care are the topics John Mandrola, MD, covers in this week’s podcast.
  theheart.org on Medscape, May 24, 2024
• HRS 2024 Read clinically focused news coverage of key developments from HRS 2024
  theheart.org on Medscape, May 21, 2024
• CPAP Underperforms: The Sequel Still room for CPAP in the cemetery for discarded medical therapies.
  Medscape Critical Care, May 15, 2024
• May 10 2024 This Week in Cardiology   Inclisiran, sodium-channel blocker safety, analytic flexibility, the work-up of patients with HF, and BP in older patients are the topics John Mandrola, MD, covers in this week’s podcast.
  theheart.org on Medscape, May 10, 2024
• May 03 2024 This Week in Cardiology   The DEDICATE trial of TAVR vs SAVR, more on renal denervation, inclisiran, and marketing disguised as science are the topics John Mandrola, MD, discusses in today’s podcast.
  theheart.org on Medscape, May 03, 2024